Linde plc vs Freeport-McMoRan, Inc. — Stock Comparison
Q·Score Breakdown
7
Buy
Overall
8.4
Buy
Quality
Health
Growth
Valuation
Sentiment
LIN
High-quality business with 18% return on equity and 20% profit margins.
⚠ valuation offers limited margin of safety.
FCX
Clean balance sheet with low leverage (0.3× debt-to-equity).
Analyst Consensus
BUY
Target $525.49 (+4.1%)
25 analysts
BUY
Target $67.90 (+17.8%)
21 analysts
Fundamentals
LIN
FCX
34.6×
Trailing P/E
30.5×
25.9×
Forward P/E
15.6×
20.3%
Profit Margin
10.3%
48.8%
Gross Margin
37.1%
17.8%
ROE
15.6%
5.8%
Revenue Growth
8.8%
-9.4%
Earnings Growth
154.0%
0.79
Beta
1.47
—
Price / Book
—
$233.9B
Market Cap
$82.7B
$388 – $516
52-Week Range
$35 – $71
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.